Ballentine Partners, LLC Edwards Lifesciences Corp Transaction History

Ballentine Partners, LLC

$6.57 Billion
Q2 2025

A detailed history of Ballentine Partners, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Ballentine Partners, LLC holds 6,072 shares of EW stock, worth $467,118. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,072

Previous 5,109 18.85%

Holding current value

$467,118

Previous $370,000 28.11%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 15, 2025	BUY	$67.07 - $78.22 $64,588 - $75,325	963 Added 18.85%	6,072 $474,000
Q1 2025 May 01, 2025	SELL	$67.95 - $76.19 $25,481 - $28,571	-375 Reduced 6.84%	5,109 $370,000
Q4 2024 Jan 16, 2025	BUY	$64.54 - $75.92 $52,277 - $61,495	810 Added 17.33%	5,484 $405,000
Q3 2024 Oct 23, 2024	SELL	$59.7 - $93.78 $39,999 - $62,832	-670 Reduced 12.54%	4,674 $308,000
Q2 2024 Aug 06, 2024	BUY	$84.3 - $94.31 $9,104 - $10,185	108 Added 2.06%	5,344 $493,000
Q1 2024 Apr 11, 2024	BUY	$72.54 - $95.56 $71,379 - $94,031	984 Added 23.14%	5,236 $500,000
Q4 2023 Jan 23, 2024	SELL	$61.71 - $77.76 $51,281 - $64,618	-831 Reduced 16.35%	4,252 $324,000
Q3 2023 Oct 19, 2023	SELL	$69.28 - $93.38 $39,489 - $53,226	-570 Reduced 10.08%	5,083 $352,000
Q2 2023 Jul 26, 2023	BUY	$81.41 - $94.33 $14,979 - $17,356	184 Added 3.36%	5,653 $533,000
Q1 2023 Apr 27, 2023	BUY	$74.26 - $84.51 $41,808 - $47,579	563 Added 11.48%	5,469 $452,000
Q4 2022 Jan 27, 2023	BUY	$68.3 - $87.44 $60,240 - $77,122	882 Added 21.92%	4,906 $0
Q3 2022 Oct 26, 2022	BUY	$82.37 - $107.29 $81,628 - $106,324	991 Added 32.67%	4,024 $333,000
Q2 2022 Aug 09, 2022	BUY	$86.5 - $128.27 $76,639 - $113,647	886 Added 41.27%	3,033 $288,000
Q1 2022 May 05, 2022	BUY	$101.96 - $128.34 $28,548 - $35,935	280 Added 15.0%	2,147 $252,000
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $531 - $653	5 Added 0.27%	1,867 $242,000
Q3 2021 Oct 27, 2021	BUY	$102.91 - $122.75 $191,618 - $228,560	1,862 New	1,862 $211,000
Q4 2020 Jan 25, 2021	SELL	$71.69 - $91.23 $318,805 - $405,699	-4,447 Closed	0 $0
Q3 2020 Oct 22, 2020	SELL	$67.19 - $87.44 $64,502 - $83,942	-960 Reduced 17.75%	4,447 $355,000
Q2 2020 Jul 31, 2020	BUY	$57.54 - $76.95 $208,697 - $279,097	3,627 Added 203.76%	5,407 $374,000
Q1 2020 Apr 23, 2020	SELL	$52.41 - $81.0 $5,031 - $7,776	-96 Reduced 5.12%	1,780 $335,000
Q3 2019 Oct 21, 2019	BUY	$61.55 - $75.43 $7,816 - $9,579	127 Added 7.26%	1,876 $412,000
Q2 2019 Jul 25, 2019	BUY	$55.74 - $64.41 $26,587 - $30,723	477 Added 37.5%	1,749 $323,000
Q1 2019 May 09, 2019	BUY	$47.89 - $64.05 $60,916 - $81,471	1,272 New	1,272 $243,000

Others Institutions Holding EW

# of Institutions

1,412

Shares Held

484M

Call Options Held

2.9M

Put Options Held

1.7M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $47.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.

Account

Ballentine Partners, LLC Edwards Lifesciences Corp Transaction History